U.S. House · 117th Congress · H.R. 4278
H.R. 4278
To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Gregory F. MurphyR-NC-3
- Introduced
- June 30, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Diana HarshbargerR-TN-1